✦ LIBER ✦

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences

✍ Scribed by M.A Nooij; J.C.J.M de Haes; L.V.A.M Beex; J Wildiers; J Klijn; D Becquart; J Jassem; E Engelsman; L Duchateau

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy Dose Escalation Might Not I

✍ Skladowski, K.A.; Wygoda, A.; Cedrych, I.; Rutkowski, T.; Hutnik, M.; Pilecki, B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

The Breast Avastin Trial: phase II study

✍ Bisagni, G.; Musolino, A.; Panebianco, M.; Matteis, A.; Nuzzo, F.; Ardizzoni, A. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 256 KB

A prognostic model based on combining es

✍ Miglietta, L.; Morabito, F.; Provinciali, N.; Canobbio, L.; Meszaros, P.; Naso, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 674 KB

12. The evaluation of clinical, histolog

✍ K. Małecki 📂 Article 📅 2001 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 119 KB

Survival prolongation after treatment fa

✍ Takashima, Atsuo; Boku, Narikazu; Kato, Ken; Nakamura, Kenichi; Mizusawa, Junki; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 375 KB

Analysis of biomarkers (P PTEN, and IGF-

✍ H. Iwata; M. Sawaki; Y. Sato; M. Wada; T. Toyama; E. Sasaki; Y. Yatabe; T. Imai 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB